JEFFREY MARTENS: Open Payments
NPI 1659374049 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$344 in 17 payments from 5 companies in 2025. Trend: 2023 $520 · 2024 $559 · 2025 $344
Food & beverage: $344
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 10 | $209 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $60 |
| Novo Nordisk Inc | 2 | $40 |
| Amgen Inc. | 1 | $19 |
| AstraZeneca Pharmaceuticals LP | 1 | $16 |
Products named: Kerendia, JARDIANCE, Wegovy, Repatha, FARXIGA.
Industry payments across OK — which companies pay providers there.
